John Schilling

John Schilling has a diverse work experience spanning over 30 years in various roles within the pharmaceutical and healthcare industry. John currently holds the position of Associate Vice President, Diagnostics Business Development at Loxo Oncology at Lilly since November 2022. Prior to this, they served as the Senior Director of Diagnostics Business Development at the same company from January 2020 to December 2022.

Before joining Loxo Oncology at Lilly, John worked at Eli Lilly and Company for over 19 years, where they held multiple leadership positions. John served as the Director of Diagnostic Business Development from December 2010 to December 2022. Earlier, they served as the Director of Global Marketing for various products including Arzoxifene, Forteo, Evista, and Arxxant (ruboxistaurin) from 2001 to 2010.

John also gained valuable experience at companies such as Bausch & Lomb as a Marketing Director from 1999 to 2001, Astra Zeneca as a Brand Manager from 1997 to 1999, Centocor as a Marketing Manager from 1996 to 1998, Bayer as a Brand/Marketing Manager from 1995 to 1996, Sanofi Pasteur as a Global Marketing Manager from 1990 to 1994, and Abbott Laboratories as a Sales Representative in 1987-1988.

Overall, John Schilling has a strong background in business development, global marketing, and management roles in the pharmaceutical and healthcare industry.

John Schilling earned a Bachelor of Science degree in Business from McMurray College in 1979. John went on to study Management at Indiana University Bloomington, where they graduated with a Bachelor of Science degree in 1983. Later, they pursued a Master of Business Administration (MBA) degree with a focus on Global Marketing and Management at Western International University from 1999 to 2001.